ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

Abstract Number: 1757
Association of the Lupus Low Disease Activity State (LLDAS) with Health-Related Quality of Life
Abstract Number: 1758
Physical Activity and Sedentary Behaviour in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Abstract Number: 1759
Sleep Disturbance Is Associated with Worsening Patient-Reported Outcomes over Two Years in Systemic Lupus Erythematosus (SLE)
Abstract Number: 1760
Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study
Abstract Number: 1761
Fatigue in Patients with Systemic Lupus Erythematosus Is Independent of Their Disease Activity but Dependent on Their Damage Accrual and Body Mass Index
Abstract Number: 1762
Systemic Lupus Erythematosus and the Evaluation of Poor Sleep
Abstract Number: 1763
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus Following 7 Years of Treatment Exposure: Impact of Clinical Characteristics over Time
Abstract Number: 1764
Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus
Abstract Number: 1765
Minimal Clinically Important Differences for Generic Patient Reported Outcomes Tools in SLE
Abstract Number: 1766
Impact of Depression on SLE Flares
Abstract Number: 1767
Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?
Abstract Number: 1768
Fatigue in SLE Is Associated with Neuropsychiatric Involvement, Pain, Impaired Sleep and a Reduced Quality of Life
Abstract Number: 1769
Fatigue in Anti-Nuclear Antibody Positive Individuals with Insufficient Criteria to Diagnose a Systemic Autoimmune Rheumatic Disease
Abstract Number: 1770
The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years
Abstract Number: 1771
Depression Is Associated with a Poorer with Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
Abstract Number: 1773
Risk Factors for Cerebrovascular Events in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
Abstract Number: 1774
Chronological Analysis of Damage Accrual in Patientes with Systemic Lupus Erythematosus: Results from the Spanish Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)
Abstract Number: 1775
Smoking As a Predictor of Cutaneous Activity in Systemic Lupus Erythematosus
Abstract Number: 1776
Analysis of Progressive Brain and Corpus Callosum Atrophy and Association with Th1 and Th2 Cytokines in Systemic Lupus Erythematosus
Abstract Number: 1777
The Accumulation of Organ Damage, Public Insurance Enrollment and Youth Are Associated with Increased Hospitalizations in a Population-Based Cohort of Lupus Patient
Abstract Number: 1778
Differences Between Early and Late Cardiovascular Disease in a Population-Based Cohort of Systemic Lupus Erythematosus Patients
Abstract Number: 1779
Remission and Low Lupus Disease Activity Status (LLDAS) Protect Lupus Patients from Damage Occurrence: Data from a Multi-Ethnic, Multinational Latin American Lupus Cohort
Abstract Number: 1780
Pulmonary Disease in Late Versus Early Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 1781
Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus
Abstract Number: 1782
Subclinical Myocarditis in Systemic Lupus Erythematosus Patients without Cardiovascular Disease
Abstract Number: 1783
Phenome-Wide Association Study Identifies a New Association of Atrial Fibrillation in Males with Systemic Lupus Erythematosus
Abstract Number: 1784
The Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Lupus Erythematosus: A Population-Based Study
Abstract Number: 1785
Prevalence and Associated Factors of Low Bone Mass in Adults with Systemic Lupus Erythmatosus
Abstract Number: 1786
Long-Term Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus in a Large Case Control Cohort Study
Abstract Number: 1787
Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus
Abstract Number: 1788
Alterations in Sense of Smell and Limbic Structures in Patients with Systemic Lupus Erythematosus during 3-Years Follow-up
Abstract Number: 1789
Herpetic Viruses in Lupus
Abstract Number: 1790
Accrual of Disease Comorbidities over 8 Years in a Multicentre Inception SLE Cohort
Abstract Number: 1791
Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia
Abstract Number: 1792
Cardiac Surgery in Systemic Lupus Erythematosus Patients: Clinical Characteristics and Outcomes
Abstract Number: 1793
Visceral Adiposity Assessed By DXA in Juvenile-Onset Systemic Lupus Erythematosus: A Correlation with Damage Index and Disease Duration
Abstract Number: 1794
The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population
Abstract Number: 1795
Four Years Follow-up of Subclinical Atherosclerosis in Systemic Lupus Erythematosus Patients
Abstract Number: 1796
Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 1797
Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus
Abstract Number: 1798
Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review
Abstract Number: 1799
Smoking, Antiphospholipid Antibodies and Thrombosis in SLE
Abstract Number: 1800
Prevalence of ECG Cardiovascular Abnormalities in Lupus Patients: A Novel Approach Using 5 ECG Elements
Abstract Number: 1801
Clinical Implications of Persistent Sinus Tachycardia in Systemic Lupus Erythematous: A Retrospective Study
Abstract Number: 1802
Prevalence of CMV in the Ohio State University Lupus Population
Abstract Number: 1803
General Features of SLE Patients Presenting with Autoimmune Hemolytic Anemia
Abstract Number: 1804
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus:  a Single Centre Experience
Abstract Number: 1805
Factors Associated with Complete Remission in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study in One Center
Abstract Number: 1806
Adherence to Treatment and Social,  Educational Levels in Patients with Systemic Lupus Erythematosus
Abstract Number: 1807
Prevalence of Progressive Multifocal Leukoencephalopathy in Adults and Children with Systemic Lupus Erythematosus
Abstract Number: 1808
Frequency and Factors Associated with Thirty Day Hospital Readmissions Among Systemic Lupus Erythematosus Patients in a Community Hospital in the California Central Valley
Abstract Number: 1809
Influence of Solar Radiation in Cutaneous Manifestations of Lupus: Data from the Gladel Cohort
Abstract Number: 1810
Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth
Abstract Number: 1811
Systemic Lupus Erythematosus: Detailed Anatomy of a Cohort (follow-up for more than 35 years). 
Abstract Number: 1812
Impact of Severe Organic CNS Involvement in Cognitive Function in a Cohort of Systemic Lupus Erythematosus Patients
Abstract Number: 1813
Prevalence and Incidence of Systemic Lupus Erythematosus in Tucuman -Argentina
Abstract Number: 1814
Epidemiology and Microbiology of Pneumonia in Systemic Lupus Erythematosus (SLE)
Abstract Number: 1815
Frequency and Predictors of Attaining the Lupus Low Disease Activity State (LLDAS) in a Multinational SLE Cohort from the Asia Pacific
Abstract Number: 1816
SLE and Uctd in the Rheumatology Informatics System for Effectiveness (RISE) Registry
Abstract Number: 1817
A Longitudinal Analysis of Change in Lupus Disease Activity Pattern in Hopkins Lupus Cohort Using a Multistate Markov Model Approach
Abstract Number: 1818
Predictors for Mortality in Hospitalized Patients with Systemic Lupus Erythematosus from 1999 to 2009: A Follow-up Multicenter Study in China
Abstract Number: 1819
Myocarditis in Systemic Lupus Erythematosus

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies